N

NKGen Biotech Inc
NASDAQ:NKGN

Watchlist Manager
NKGen Biotech Inc
NASDAQ:NKGN
Watchlist
Price: 0.18 USD Market Closed
Market Cap: $23.5m

Cash Flow Statement

Cash Flow Statement
NKGen Biotech Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025
Operating Cash Flow
Net Income
1
10
6
5
3
(4)
(52)
(83)
(89)
(103)
(48)
(44)
(24)
Depreciation & Amortization
0
0
0
0
0
0
1
1
1
2
1
1
1
Change in Deffered Taxes
0
(0)
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
0
0
0
1
2
3
4
4
4
4
4
4
Other Non-Cash Items
(4)
(14)
(10)
(8)
(7)
(2)
34
58
58
69
21
21
3
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
1
1
1
Change in Working Capital
1
3
3
2
2
3
1
2
4
2
5
1
(0)
Cash from Operating Activities
(2)
N/A
(1)
+58%
(1)
-55%
(2)
-35%
(2)
-15%
(2)
-21%
(16)
-618%
(22)
-41%
(25)
-16%
(31)
-21%
(21)
+33%
(21)
0%
(20)
+6%
Investing Cash Flow
Capital Expenditures
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other Items
0
0
0
1
1
114
0
0
113
0
0
0
0
Cash from Investing Activities
0
N/A
0
N/A
0
N/A
1
N/A
1
+14%
114
+17 426%
1
-100%
(0)
N/A
(0)
-94%
(113)
-121 812%
(0)
+100%
(0)
+13%
(0)
-669%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
(113)
12
12
12
126
1
1
1
Net Issuance of Debt
0
0
0
0
0
0
26
26
28
33
10
14
13
Other
0
0
0
(0)
0
0
(14)
(16)
(14)
(15)
1
6
5
Cash from Financing Activities
0
N/A
0
N/A
0
N/A
(0)
N/A
0
N/A
(113)
N/A
24
N/A
22
-7%
26
+18%
145
+455%
12
-92%
21
+73%
19
-7%
Change in Cash
Net Change in Cash
1
N/A
(1)
N/A
(1)
-55%
(1)
+6%
(1)
-14%
(1)
+2%
9
N/A
0
-98%
1
+275%
1
+34%
(9)
N/A
(0)
+100%
(0)
-522%
Free Cash Flow
Free Cash Flow
(2)
N/A
(1)
+58%
(1)
-55%
(2)
-35%
(2)
-15%
(2)
-21%
(16)
-620%
(22)
-41%
(26)
-16%
(31)
-21%
(21)
+32%
(21)
0%
(20)
+6%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett